Nanoneedle Bio-patch Provides Minimally Invasive Drug Delivery
By LabMedica International staff writers Posted on 20 Nov 2018 |
Image: Silicon nanoneedles embedded in a stretchable and translucent elastomer patch that can be worn on the skin to deliver exact doses of drugs directly into cells (Photo courtesy of Purdue University).
A flexible bio-patch made from silicon nanoneedles embedded in a thin layer of elastomer was shown to deliver exact doses of biomolecules to cells and tissues while minimizing discomfort to the wearer.
Vertically ordered arrays of silicon nanoneedles – due to their nanoscale dimension and low cytotoxicity – are capable of minimally invasive nanoinjection of biomolecules into living biological systems such as cells and tissues. Nanoneedle bio-patches are usually fabricated on a bulk silicon wafer that is able to withstand the high temperatures and corrosive chemicals employed in standard nanofabrication processes. These rigid, flat, and opaque silicon wafers do not conform favorably with the soft, curvilinear, and optically transparent biological systems for which they are intended.
To improve this situation, investigators at Purdue University (West Lafayette, IN, USA) developed a unique methodology that enabled construction of vertically ordered silicon nanoneedles on a thin layer of elastomer patch that could flexibly and transparently interface with biological systems.
The investigators reported in the November 9, 2018, online edition of the journal Science Advances that this methodology allowed the heterogeneous integration of vertically ordered silicon nanoneedles with a thin layer of elastomer patch, which could provide a certain degree of mechanical flexibility, optical transparency, and cell and tissue compatibility.
"This means that eight or nine silicon nanoneedles can be injected into a single cell without significantly damaging a cell. So we can use these nanoneedles to deliver biomolecules into cells or even tissues with minimal invasiveness," said senior author Dr. Chi Hwan Lee, assistant professor in of biomedical engineering at Purdue University. "This nanoneedle patch is not only flexible but also transparent, and therefore can also allow simultaneous real-time observation of the interaction between cells and nanoneedles."
Related Links:
Purdue University
Vertically ordered arrays of silicon nanoneedles – due to their nanoscale dimension and low cytotoxicity – are capable of minimally invasive nanoinjection of biomolecules into living biological systems such as cells and tissues. Nanoneedle bio-patches are usually fabricated on a bulk silicon wafer that is able to withstand the high temperatures and corrosive chemicals employed in standard nanofabrication processes. These rigid, flat, and opaque silicon wafers do not conform favorably with the soft, curvilinear, and optically transparent biological systems for which they are intended.
To improve this situation, investigators at Purdue University (West Lafayette, IN, USA) developed a unique methodology that enabled construction of vertically ordered silicon nanoneedles on a thin layer of elastomer patch that could flexibly and transparently interface with biological systems.
The investigators reported in the November 9, 2018, online edition of the journal Science Advances that this methodology allowed the heterogeneous integration of vertically ordered silicon nanoneedles with a thin layer of elastomer patch, which could provide a certain degree of mechanical flexibility, optical transparency, and cell and tissue compatibility.
"This means that eight or nine silicon nanoneedles can be injected into a single cell without significantly damaging a cell. So we can use these nanoneedles to deliver biomolecules into cells or even tissues with minimal invasiveness," said senior author Dr. Chi Hwan Lee, assistant professor in of biomedical engineering at Purdue University. "This nanoneedle patch is not only flexible but also transparent, and therefore can also allow simultaneous real-time observation of the interaction between cells and nanoneedles."
Related Links:
Purdue University
Latest BioResearch News
- Genome Analysis Predicts Likelihood of Neurodisability in Oxygen-Deprived Newborns
- Gene Panel Predicts Disease Progession for Patients with B-cell Lymphoma
- New Method Simplifies Preparation of Tumor Genomic DNA Libraries
- New Tool Developed for Diagnosis of Chronic HBV Infection
- Panel of Genetic Loci Accurately Predicts Risk of Developing Gout
- Disrupted TGFB Signaling Linked to Increased Cancer-Related Bacteria
- Gene Fusion Protein Proposed as Prostate Cancer Biomarker
- NIV Test to Diagnose and Monitor Vascular Complications in Diabetes
- Semen Exosome MicroRNA Proves Biomarker for Prostate Cancer
- Genetic Loci Link Plasma Lipid Levels to CVD Risk
- Newly Identified Gene Network Aids in Early Diagnosis of Autism Spectrum Disorder
- Link Confirmed between Living in Poverty and Developing Diseases
- Genomic Study Identifies Kidney Disease Loci in Type I Diabetes Patients
- Liquid Biopsy More Effective for Analyzing Tumor Drug Resistance Mutations
- New Liquid Biopsy Assay Reveals Host-Pathogen Interactions
- Method Developed for Enriching Trophoblast Population in Samples